New health regulation from SGK: Two new drugs and surgical procedures are within the scope of reimbursement

The new regulations of the Social Security Institution (SGK) regarding health services were published in the Official Gazette. Minister of Labor and Social Security Vedat Işıkhan announced that with the changes made in the Health Implementation Communiqué (SUT), two drugs were included in the scope of reimbursement and regulations for some surgical procedures were implemented.

In his statement on his NSosyal account, Minister Işıkhan stated that the regulations were carried out with the understanding of effective, sustainable and accessible health care.

NEW REGULATION FOR NEWBORN AND CHILD PATIENTS

With the new regulation, surgical procedures performed using advanced technology for newborn and pediatric patients are included in the scope of reimbursement.

In addition, reimbursement was provided for a drug used in the treatment of early stage breast cancer and another drug used in the treatment of a rare disease involving the optic nerve.

PATIENTS WAITING FOR ORGAN TRANSPLANTATION ARE ALSO IN THE COVERAGE

SSI's regulation also included practices for patients waiting for organ transplantation. Minister Işıkhan stated that regulations have been implemented to ensure the uninterrupted progress of organ preservation protocols.

Işıkhan used the following statements in his statement:

"We have included within the scope of reimbursement surgical procedures performed with advanced technology for newborn and pediatric patients, one drug to be used in the treatment of early stage breast cancer, and one drug used in the treatment of a rare disease involving the involvement of the optic nerve. We have also implemented regulations that will ensure the uninterrupted progress of vital organ preservation protocols for our patients waiting for organ transplantation. I wish a speedy recovery to our patients and wish them well."